Platensimycin and Platencin

Natural Products in Medicinal Chemistry

Volumn , Issue , 2014, Pages 271-300

  Ghosh, Arun K ^a   Xi, Kai ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Antibiotic resistance; Antibiotics; Bacteria; MRSA; Platencin; Platensimycin

Indexed keywords

EID: 84926474432     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527676545.ch08     Document Type: Chapter

References (77)

1. Bentivoglio, M. and Pacini, P. (1995) Filippo Pacini: a determined observer. Brain Research Bulletin, 38, 161-165.
2. Howard-Jones, N. (1984) Robert Koch and the cholera vibrio: a centenary. British Medical Journal, 288, 379-381.
3. Yarnel, A. (2005) Salvarsan. Chemical Engineering News, 83, (250), 116.
4. Hager, T. (2006) The Demon Under the Microscope: From Battlefield Hospitals to Nazi Labs, One Doctor's Heroic Search for the World's First Miracle Drug, The Crown Publishing Group.
5. Diggins, F. (2003) The true history of the discovery of penicillin by Alexander Fleming. Biomedical Scientist. Institute of Biomedical Sciences, London (originally published in the Imperial College School of Medicine Gazette).
6. Walsh, C. (2003) Antibiotics: Actions, Origins, Resistance, ASM Press, Washington, DC.
7. Singh, S.B. and Barrett, J.F. (2006) Empirical antibacterial drug discovery -foundation in natural products. Biochemical Pharmacology, 71, 1006-1015.
8. Patrick, G.L. (2001) An Introduction to Medicinal Chemistry, Oxford University Press Inc., New York.
9. von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., and Häbich, D. (2006) Antibacterial natural products in medicinal chemistry -exodus or revival? Angewandte Chemie -International Edition, 45, 5072-5129.
10. Davies, J. and Davies, D. (2010) Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews, 74, 417-433.
11. Bennett, P.M. and Chopra, I. (1993) Molecular basis of b-lactamase induction in bacteria. Antimicrobial Agents and Chemotherapy, 37, 153-158.
12. Crisostomo, M.I., Westh, H., Tomasz, A., Chung, M., Oliveira, D.C., and deLencastre, H. (2001) The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proceedings of the National Academy of Sciences of the United States of America, 98, 9865-9870.
13. Chambers, H.F. (2001) The changing epidemiology of Staphylococcus aureus? Emerging Infectious Diseases, 7, 178-182.
14. Levine, D. (2006) Vancomycin: a history. Clinical Infectious Diseases, 42, S5-S12.
15. Barbachyn, M.R. and Ford, C.W. (2003) Oxazolidinone structure-activity relationships leading to linezolid. Angewandte Chemie -International Edition, 42, 2010-2023.
16. Bersos, Z., Maniati, M., Kontos, F., Petinaki, E., and Maniatis, A.N. (2004) First report of a linezolid-resistant vancomycin-resistant Enterococcus faecium strain in Greece. The Journal of Antimicrobial Chemotherapy, 53, 685-686.
17. Moellering, R.C., Jr. (1998) Antibiotic resistance: lessons for the future. Clinical Infectious Diseases, 27, S135-S140.
18. Koirala, K.D. and Thapa, S.D. (2011) Antibiotic resistance and the future. The Journal of the American Medical Association, 305, 2293-2294.
19. Wright, H.T. and Reynolds, K.A. (2007) Antibacterial targets in fatty acid biosynthesis. Current Opinion in Microbiology, 10, 447-453.
20. Zhang, Y.M., White, S.W., and Rock, C.O. (2006) Inhibiting bacterial fatty acid synthesis. The Journal of Biological Chemistry, 281, 17541-17544.
21. Bergler, H., Fuchbichler, S., Hogenauer, G., and Turnowsky, F. (1996) The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA. European Journal of Biochemistry, 242, 689-694.
22. Heath, R.J., Su, N., Murphy, C.K., and Rock, C.O. (2000) The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis. The Journal of Biological Chemistry, 275, 40128-40133.
23. Sivaraman, S., Sullivan, T.J., Johnson, F., Novichenok, P., Cui, G., Simmerling, C., and Tonge, P.J. (2004) Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure-reactivity analysis of FabI inhibition by triclosan analogs. Journal of Medicinal Chemistry, 47, 509-518.
24. Schulman, G.E., Choi, K.-H., Altabe, S., Rock, C.O., and de Mendoza, D. (2001) Response of Bacillus subtilis to cerulenin and acquisition of resistance. Journal of Bacteriology, 183, 3032-3040.
25. Young, K., Jayasuriya, H., Ondeyka, J.G., Herath, K., Zhang, C., Kodali, S., Galgoci, A., Painter, R., Brown-Driver, V., Yamamoto, R., Silver, L.L., Zheng, Y., Ventura, J.I., Sigmund, J., Ha, S., Basilio, A., Vicente, F., Tormo, J.R., Pelaez, F., Youngman, P., Cully, D., Barrett, J.F., Schmatz, D., Singh, S.B., and Wang, J. (2006) Discovery of FabH/ FabF inhibitors from natural products. Antimicrobial Agents and Chemotherapy, 50, 519-526.
26. Wang, J., Soisson, S.M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y.S., Cummings, R., Ha, S., Dorso, K., Motyl, M., Jayasuriya, H., Ondeyka, J., Herath, K., Zhang, C.W. et al. (2006) Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature, 441, 358-361.
27. Singh, S.B., Jayasuriya, H., Ondeyka, J.G., Herath, K.B., Zhang, C.W., Zink, D.L., Tsou, N.N., Ball, R.G., Basilio, A., Genilloud, O., Diez, M.T., Vicente, F., Pelaez, F., Young, K., and Wang, J. (2006) Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy. Journal of the American Chemical Society, 128, 11916-11920.
28. Wang, J., Kodali, S., Lee, S.H., Galgoci, A., Painter, R., Dorso, K., Racine, F., Motyl, M., Hernandez, L., Tinney, E., Colletti, S.L., Herath, K. et al. (2007) Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties. Proceedings of the National Academy of Sciences of the United States of America, 104, 7612-7616.
29. Jayasuriya, H., Herath, K.B., Zhang, C., Zink, D.L., Basilio, A., Genilloud, O. et al. (2007) Isolation and structure of platencin: a FabH and FabF dual inhibitor with potent broad-spectrum antibiotic activity. Angewandte Chemie-International Edition, 46, 4684-4688.
30. Habich, D. and von Nussbaum, F. (2006) Platensimycin, a new antibiotic and "superbug challenger" from nature. ChemMedChem, 1, 951-954.
31. Herath, K.B., Attygalle, A.B., and Singh, S.B. (2007) Biosynthetic studies of platensimycin. Journal of the American Chemical Society, 129, 15422-15423.
32. Herath, K., Attygalle, A.B., and Singh, S.B. (2008) Biosynthetic studies of platencin. Tetrahedron Letters, 49, 5755-5758.
33. Lu, X. and You, Q. (2010) Recent advances of platensimycin: a potential antimicrobial agent. Current Medicinal Chemistry, 17, 1139-1155.
34. Manallack, D.T., Crosby, I.T., Khakham, Y., and Capuano, B. (2008) Platensimycin: a promising antimicrobial targeting fatty acid synthesis. Current Medicinal Chemistry, 15, 705-710.
35. Palanichamy, K. and Kaliappan, K.P. (2010) Discovery and syntheses of "superbug challengers"-platensimycin and platencin. Chemistry -An Asian Journal, 5, 668-703.
36. Hanessian, S., Giroux, S., and Merner, B.L. (2012) Total Synthesis from Terpenes in Design and Strategy in Organic Synthesis: From the Chiron Approach to Catalysis, Wiley-VCH Verlag GmbH, Weinheim, pp. 465-526, Chapter 13.
37. Nicolaou, K.C., Li, A., and Edmonds, D.J. (2006) Total synthesis of platensimycin. Angewandte Chemie -International Edition, 45, 7086-7090.
38. Nicolaou, K.C., Edmonds, D.J., Li, A., and Tria, G.S. (2007) Asymmetric total syntheses of platensimycin. Angewandte Chemie -International Edition, 46, 3942-3945.
39. Ghosh, A.K. and Xi, K. (2007) Enantioselective synthesis of (-)-platensimycin oxatetracyclic core by using an intramolecular Diels-Alder reaction. Organic Letters, 9, 4013-4016.
40. Ghosh, A.K. and Xi, K. (2009) Total synthesis of (-)-platensimycin, a novel antibacterial agent. The Journal of Organic Chemistry, 74, 1163-1170.
41. Li, P.F., Payette, J.N., and Yamamoto, H. (2007) Enantioselective route to platensimycin: an intramolecular Robinson annulation approach. Journal of the American Chemical Society, 129, 9534-9535.
42. Ishihara, K., Kurihara, H., Matsumoto, M., and Yamamoto, H. (1998) Design of Brønsted acid-assisted chiral Lewis acid (BLA) catalysts for highly enantioselective Diels-Alder reactions. Journal of the American Chemical Society, 120, 6920-6930.
43. Zou, Y.F., Chen, C.H., Taylor, C.D., Foxman, B.M., and Snider, B.B. (2007) Formal synthesis of (±)-platensimycin. Organic Letters, 9, 1825-1828.
44. Kim, C.H., Jang, K.P., Choi, S.Y., Chung, Y.K., and Lee, E. (2008) A carbonyl ylide cycloaddition approach to platensimycin. Angewandte Chemie -International Edition, 47, 4009-4011.
45. Lalic, G. and Corey, E.J. (2007) An effective enantioselective route to the platensimycin core. Organic Letters, 9, 4921-4923.
46. Magnus, P., Rivera, H., and Lynch, V. (2010) Concise formal total synthesis of platensimycin mediated by a stereoselective autoxidation and hydroxyl group directed conjugative reduction. Organic Letters, 12, 5677-5679.
47. Tiefenbacher, K., Trondlin, L., Mulzer, J., and Pfaltz, A. (2010) An expeditious asymmetric formal synthesis of the antibiotic platensimycin. Tetrahedron, 66, 6508-6513.
48. Nicolaou, K.C., Tria, G.S., and Edmonds, D.J. (2008) Total synthesis of platencin. Angewandte Chemie -International Edition, 47, 1780-1783.
49. Huang, Y., Iwama, T., and Rawal, V. (2002) Design and development of highly effective Lewis acid catalysts for enantioselective Diels-Alder reactions. Journal of the American Chemical Society, 124, 5950-5951.
50. Nicolaou, K.C., Toh, Q.Y., and Chen, D.Y.K. (2008) An expedient asymmetric synthesis of platencin. Journal of the American Chemical Society, 130, 11292-11293.
51. Corey, E.J., Bakshi, R.K., and Shibata, S. (1987) Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines. Mechanism and synthetic implications. Journal of the American Chemical Society, 109, 5551-5553.
52. Ghosh, A.K. and Xi, K. (2009) A symmetry-based concise formal synthesis of platencin, a novel lead against "superbugs". Angewandte Chemie-International Edition, 48, 5372-5375.
53. Hayashida, J. and Rawal, V.H. (2008) Total synthesis of (±)-platencin. Angewandte Chemie -International Edition, 47, 4373-4376.
54. Tiefenbacher, K. and Mulzer, J. (2008) Short formal synthesis of (-)-platencin. Angewandte Chemie -International Edition, 47, 6199-6200.
55. Tiefenbacher, K. and Mulzer, J. (2009) A nine-step total synthesis of (-)-platencin. The Journal of Organic Chemistry, 74, 2937-2941.
56. Jayasuriya, H., Herath, K.B., Ondeyka, J.G., Zink, D.L., Burgess, B., Wang, J., and Singh, S.B. (2008) Structure of homoplatensimide A: a potential key biosynthetic intermediate of platensimycin isolated from Streptomyces platensis. Tetrahedron Letters, 49, 3648-3651.
57. Herath, K.B., Zhang, C., Jayasuriya, H., Ondeyka, J.G., Zink, D.L., Burgess, B., Wang, J., and Singh, S.B. (2008) Structure and semisynthesis of platensimide A, produced by Streptomyces platensis. Organic Letters, 10, 1699-1702.
58. Zhang, C.W., Ondeyka, J., Zink, D.L., Burgess, B., Wang, J., and Singh, S.B. (2008) Isolation, structure and fatty acid synthesis inhibitory activities of platensimycin B1-B3 from Streptomyces platensis. Chemical Communications, 5034-5036.
59. 1 from Streptomyces platensis. Tetrahedron Letters, 50, 5182-5185.
60. 1 from Streptomyces platensis. Bioorganic & Medicinal Chemistry Letters, 19, 4756-4759.
61. 4 from Streptomyces platensis. Bioorganic & Medicinal Chemistry, 18, 2602-2610.
62. Nicolaou, K.C., Tang, Y.F., Wang, J.H., Stepan, A.F., Li, A., and Montero, A. (2007) Total synthesis and antibacterial properties of carbaplatensimycin. Journal of the American Chemical Society, 129, 14850-14851.
63. Nicolaou, K.C., Lister, T., Denton, R.M., Montero, A., and Edmonds, D.J. (2007) Adamantaplatensimycin: a bioactive analogue of platensimycin. Angewandte Chemie -International Edition, 46, 4712-4714.
64. Nicolaou, K.C., Stepan, A.F., Lister, T., Li, A., Montero, A., Tria, G.S., Turner, C.I., Tang, Y.F., Wang, J.H., Denton, R.M., and Edmonds, D.J. (2008) Design, synthesis, and biological evaluation of platensimycin analogues with varying degrees of molecular complexity. Journal of the American Chemical Society, 130, 13110-13119.
65. Jang, K.P., Kim, C.H., Na, S.W., Kim, H., Kang, H., and Lee, E. (2009) Isoplatensimycin: synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters, 19, 4601-4602.
66. Shen, H.C., Ding, F.X., Singh, S.B., Parthasarathy, G., Soisson, S.M., Ha, S.N., Chen, X., Kodali, S., Wang, J., Dorso, K., Tata, J.R., Hammond, M.L., MacCoss, M., and Colletti, S.L. (2009) Synthesis and biological evaluation of platensimycin analogs. Bioorganic & Medicinal Chemistry Letters, 19, 1623-1627.
67. Wang, J.X. and Sintim, H.O. (2011) Dialkylamino-2,4-dihydroxybenzoic acids as easily synthesized analogues of platensimycin and platencin with comparable antibacterial properties. Chemistry -A European Journal, 17, 3352-3357.
68. Jang, K.P., Kim, C.H., Na, S.W., Jang, D.S., Kim, H., Kang, H., and Lee, E. (2010) 7-Phenylplatensimycin and 11-methyl-7-phenylplatensimycin: more potent analogs of platensimycin. Bioorganic & Medicinal Chemistry Letters, 20, 2156-2158.
69. Barykina, O.V., Rossi, K.L., Rybak, M.J., and Snider, B.B. (2009) Synthesis and antibacterial properties of (-)-nor-platencin. Organic Letters, 11, 5334-5337.
70. Tiefenbacher, K., Gollner, A., and Mulzer, J. (2010) Syntheses and antibacterial properties of iso-platencin, Cl-iso-platencin and Cl-platencin: identification of a new lead structure. Chemistry -A European Journal, 16, 9616-9622.
71. Waalboer, D.C.J., Leenders, S., Schulin-Casonato, T., vanDelft, F.L., and Rutjes, F. (2010) Total synthesis and antibiotic activity of dehydrohomoplatencin. Chemistry -A European Journal, 16, 11233-11236.
72. Brinster, S., Lamberet, G., Staels, B., Trieu-Cuot, P., Gruss, A., and Poyart, C. (2009) Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature, 458, 83-86.
73. Balemans, W., Lounis, N., Gilissen, R., Guillemont, J., Simmen, K., Andries, K., and Koul, A. (2010) Essentiality of FASII pathway for Staphylococcus aureus. Nature, 463, E3-E3.
74. Brinster, S., Lamberet, G., Staels, B., Trieu-Cuot, P., Gruss, A., and Poyart, C. (2010) Brinster et al. reply. Nature, 463, E4-E4.
75. Parsons, J.B., Frank, M.W., Subramanian, C., Saenkham, P., and Rock, C.O. (2011) Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 108, 15378-15383.
76. Brown, A.K., Taylor, R.C., Bhatt, A., Fütterer, K., and Besra, G.S. (2009) Platensimycin activity against mycobacterial b-ketoacyl-ACP synthases. PLOS ONE, 4, e6306.
77. Wu, M., Singh, S.B., Wang, J., Chung, C.C., Salituro, G., Karanam, B.V., Lee, S.H., Powles, M., Ellsworth, K.P., Lassman, M. E., Miller, C., Myers, R.W., Tota, M.R., Zhang, B.B., and Li, C. (2011) Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes. Proceedings of the National Academy of Sciences of the United States of America, 108, 5378-5383.